Unknown

Dataset Information

0

Adverse Clinical Outcome Associated With Mutations That Typify African American Colorectal Cancers.


ABSTRACT: African Americans have the highest incidence and mortality from colorectal cancer (CRC) of any US racial group. We recently described a panel of 15 genes that are statistically significantly more likely to be mutated in CRCs from African Americans than in Caucasians (AA-CRC genes). The current study investigated the outcomes associated with these mutations in African American CRCs (AA-CRCs). In a cohort of 66 patients with stage I-III CRCs, eight of 27 CRCs with AA-CRC gene mutations (Mut+) developed metastatic disease vs only four of 39 mutation-negative (Mut-) cases (P = .03, Cox regression model with two-sided Wald test). Moreover, among stage III cases (n?=?33), Mut+ cancers were nearly three times more likely to relapse as Mut- cases (7 of 15 Mut+ vs 3 of 18 Mut-; P = .03, Cox regression model with two-sided Wald test). AA-CRC mutations may thus define a high-risk subset of CRCs that contributes to the overall disparity in CRC outcomes observed in African Americans.

SUBMITTER: Wang Z 

PROVIDER: S-EPMC5241897 | biostudies-other | 2016 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Adverse Clinical Outcome Associated With Mutations That Typify African American Colorectal Cancers.

Wang Zhenghe Z   Li Li L   Guda Kishore K   Chen Zhengyi Z   Barnholtz-Sloan Jill J   Park Young Soo YS   Markowitz Sanford D SD   Willis Joseph J  

Journal of the National Cancer Institute 20160831 12


African Americans have the highest incidence and mortality from colorectal cancer (CRC) of any US racial group. We recently described a panel of 15 genes that are statistically significantly more likely to be mutated in CRCs from African Americans than in Caucasians (AA-CRC genes). The current study investigated the outcomes associated with these mutations in African American CRCs (AA-CRCs). In a cohort of 66 patients with stage I-III CRCs, eight of 27 CRCs with AA-CRC gene mutations (Mut+) deve  ...[more]